annual D&A:
$9.53M-$2.36M(-19.85%)Summary
- As of today (September 14, 2025), CYTK annual depreciation & amortization is $9.53 million, with the most recent change of -$2.36 million (-19.85%) on December 31, 2024.
- During the last 3 years, CYTK annual D&A has fallen by -$106.00 thousand (-1.10%).
- CYTK annual D&A is now -19.85% below its all-time high of $11.89 million, reached on December 31, 2023.
Performance
CYTK Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$2.29M-$15.00K(-0.65%)Summary
- As of today (September 14, 2025), CYTK quarterly depreciation & amortization is $2.29 million, with the most recent change of -$15.00 thousand (-0.65%) on June 30, 2025.
- Over the past year, CYTK quarterly D&A has dropped by -$121.00 thousand (-5.03%).
- CYTK quarterly D&A is now -63.93% below its all-time high of $6.33 million, reached on December 31, 2023.
Performance
CYTK quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$9.38M-$121.00K(-1.27%)Summary
- As of today (September 14, 2025), CYTK TTM depreciation & amortization is $9.38 million, with the most recent change of -$121.00 thousand (-1.27%) on June 30, 2025.
- Over the past year, CYTK TTM D&A has dropped by -$1.68 million (-15.16%).
- CYTK TTM D&A is now -30.44% below its all-time high of $13.48 million, reached on September 30, 2024.
Performance
CYTK TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CYTK Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.9% | -5.0% | -15.2% |
| 3 y3 years | -1.1% | +14.1% | -22.7% |
| 5 y5 years | +637.1% | +449.3% | +504.7% |
CYTK Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.9% | +13.5% | -63.9% | >+9999.0% | -30.4% | +13.0% |
| 5 y | 5-year | -19.9% | +637.1% | -63.9% | >+9999.0% | -30.4% | +504.7% |
| alltime | all time | -19.9% | +2101.2% | -63.9% | +814.1% | -30.4% | +2165.5% |
CYTK Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $2.29M(-0.7%) | $9.38M(-1.3%) |
| Mar 2025 | - | $2.30M(-3.5%) | $9.50M(-0.3%) |
| Dec 2024 | $9.53M(-19.9%) | $2.38M(-1.2%) | $9.53M(-29.3%) |
| Sep 2024 | - | $2.41M(+0.2%) | $13.48M(+22.0%) |
| Jun 2024 | - | $2.41M(+3.2%) | $11.05M(-3.4%) |
| Mar 2024 | - | $2.33M(-63.2%) | $11.44M(-3.8%) |
| Dec 2023 | $11.89M(+41.6%) | $6.33M(<-9900.0%) | $11.89M(+43.3%) |
| Sep 2023 | - | -$17.00K(-100.6%) | $8.30M(-20.2%) |
| Jun 2023 | - | $2.79M(+0.3%) | $10.40M(+8.2%) |
| Mar 2023 | - | $2.78M(+1.5%) | $9.61M(+14.5%) |
| Dec 2022 | $8.40M(-12.8%) | $2.74M(+31.3%) | $8.40M(+0.6%) |
| Sep 2022 | - | $2.09M(+4.3%) | $8.35M(-31.2%) |
| Jun 2022 | - | $2.00M(+27.7%) | $12.13M(+13.7%) |
| Mar 2022 | - | $1.57M(-41.7%) | $10.67M(+10.7%) |
| Dec 2021 | $9.64M(+426.3%) | $2.69M(-54.2%) | $9.64M(+29.9%) |
| Sep 2021 | - | $5.87M(+980.8%) | $7.42M(+255.5%) |
| Jun 2021 | - | $543.00K(+1.1%) | $2.09M(+6.5%) |
| Mar 2021 | - | $537.00K(+14.0%) | $1.96M(+7.0%) |
| Dec 2020 | $1.83M(+41.6%) | $471.00K(-12.1%) | $1.83M(+4.6%) |
| Sep 2020 | - | $536.00K(+28.8%) | $1.75M(+12.9%) |
| Jun 2020 | - | $416.00K(+2.0%) | $1.55M(+9.6%) |
| Mar 2020 | - | $408.00K(+4.3%) | $1.42M(+9.4%) |
| Dec 2019 | $1.29M(+4.4%) | $391.00K(+16.4%) | $1.29M(+122.2%) |
| Sep 2019 | - | $336.00K(+20.0%) | $582.00K(+13.2%) |
| Jun 2019 | - | $280.00K(-2.1%) | $514.00K(-39.7%) |
| Mar 2019 | - | $286.00K(-189.4%) | $852.00K(-31.2%) |
| Dec 2018 | $1.24M(-35.5%) | -$320.00K(-219.4%) | $1.24M(-42.9%) |
| Sep 2018 | - | $268.00K(-56.6%) | $2.17M(-7.7%) |
| Jun 2018 | - | $618.00K(-8.2%) | $2.35M(+8.2%) |
| Mar 2018 | - | $673.00K(+10.3%) | $2.17M(+13.1%) |
| Dec 2017 | $1.92M(+159.1%) | $610.00K(+35.6%) | $1.92M(+25.2%) |
| Sep 2017 | - | $450.00K(+2.5%) | $1.53M(+21.6%) |
| Jun 2017 | - | $439.00K(+4.3%) | $1.26M(+27.1%) |
| Mar 2017 | - | $421.00K(+87.9%) | $992.00K(+33.9%) |
| Dec 2016 | $741.00K(+25.8%) | $224.00K(+26.6%) | $741.00K(+10.9%) |
| Sep 2016 | - | $177.00K(+4.1%) | $668.00K(+4.9%) |
| Jun 2016 | - | $170.00K(0.0%) | $637.00K(+3.7%) |
| Mar 2016 | - | $170.00K(+12.6%) | $614.00K(+4.2%) |
| Dec 2015 | $589.00K(+20.2%) | $151.00K(+3.4%) | $589.00K(+2.4%) |
| Sep 2015 | - | $146.00K(-0.7%) | $575.00K(+3.6%) |
| Jun 2015 | - | $147.00K(+1.4%) | $555.00K(+4.7%) |
| Mar 2015 | - | $145.00K(+5.8%) | $530.00K(+8.2%) |
| Dec 2014 | $490.00K | $137.00K(+8.7%) | $490.00K(+11.1%) |
| Sep 2014 | - | $126.00K(+3.3%) | $441.00K(+6.0%) |
| Jun 2014 | - | $122.00K(+16.2%) | $416.00K(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $105.00K(+19.3%) | $414.00K(-4.4%) |
| Dec 2013 | $433.00K(-26.7%) | $88.00K(-12.9%) | $433.00K(-8.6%) |
| Sep 2013 | - | $101.00K(-15.8%) | $474.00K(-7.6%) |
| Jun 2013 | - | $120.00K(-3.2%) | $513.00K(-4.5%) |
| Mar 2013 | - | $124.00K(-3.9%) | $537.00K(-9.1%) |
| Dec 2012 | $591.00K(-54.4%) | $129.00K(-7.9%) | $591.00K(-14.5%) |
| Sep 2012 | - | $140.00K(-2.8%) | $691.00K(-14.3%) |
| Jun 2012 | - | $144.00K(-19.1%) | $806.00K(-23.4%) |
| Mar 2012 | - | $178.00K(-22.3%) | $1.05M(-18.9%) |
| Dec 2011 | $1.30M(-31.7%) | $229.00K(-10.2%) | $1.30M(-15.3%) |
| Sep 2011 | - | $255.00K(-34.6%) | $1.53M(-12.4%) |
| Jun 2011 | - | $390.00K(-7.8%) | $1.75M(-4.7%) |
| Mar 2011 | - | $423.00K(-8.6%) | $1.83M(-3.5%) |
| Dec 2010 | $1.90M(-6.0%) | $463.00K(-1.7%) | $1.90M(-1.6%) |
| Sep 2010 | - | $471.00K(-1.3%) | $1.93M(-1.5%) |
| Jun 2010 | - | $477.00K(-2.5%) | $1.96M(-1.7%) |
| Mar 2010 | - | $489.00K(-1.0%) | $2.00M(-1.3%) |
| Dec 2009 | $2.02M(-17.7%) | $494.00K(-1.4%) | $2.02M(-3.3%) |
| Sep 2009 | - | $501.00K(-2.0%) | $2.09M(-5.3%) |
| Jun 2009 | - | $511.00K(-0.8%) | $2.21M(-5.3%) |
| Mar 2009 | - | $515.00K(-8.5%) | $2.33M(-5.0%) |
| Dec 2008 | $2.46M(-13.2%) | $563.00K(-9.0%) | $2.46M(-3.8%) |
| Sep 2008 | - | $619.00K(-2.5%) | $2.55M(-2.0%) |
| Jun 2008 | - | $635.00K(-0.6%) | $2.60M(-4.1%) |
| Mar 2008 | - | $639.00K(-3.0%) | $2.71M(-4.1%) |
| Dec 2007 | $2.83M(-3.3%) | $659.00K(-1.6%) | $2.83M(-1.6%) |
| Sep 2007 | - | $670.00K(-10.1%) | $2.88M(-1.9%) |
| Jun 2007 | - | $745.00K(-1.3%) | $2.93M(+0.0%) |
| Mar 2007 | - | $755.00K(+6.9%) | $2.93M(+0.1%) |
| Dec 2006 | $2.93M(-4.4%) | $706.00K(-2.8%) | $2.93M(-1.2%) |
| Sep 2006 | - | $726.00K(-2.4%) | $2.96M(-1.1%) |
| Jun 2006 | - | $744.00K(-0.9%) | $3.00M(-0.9%) |
| Mar 2006 | - | $751.00K(+1.1%) | $3.02M(-1.2%) |
| Dec 2005 | $3.06M(-6.5%) | $743.00K(-2.2%) | $3.06M(-2.3%) |
| Sep 2005 | - | $760.00K(-1.4%) | $3.13M(-2.1%) |
| Jun 2005 | - | $771.00K(-2.2%) | $3.20M(-1.4%) |
| Mar 2005 | - | $788.00K(-3.3%) | $3.25M(-0.9%) |
| Dec 2004 | $3.28M(+3.0%) | $815.00K(-1.5%) | $3.28M(+33.1%) |
| Sep 2004 | - | $827.00K(+1.5%) | $2.46M(+50.6%) |
| Jun 2004 | - | $815.00K(-0.5%) | $1.63M(+99.5%) |
| Mar 2004 | - | $819.00K | $819.00K |
| Dec 2003 | $3.18M(+11.7%) | - | - |
| Dec 2002 | $2.85M(+76.5%) | - | - |
| Dec 2001 | $1.61M(+87.7%) | - | - |
| Dec 2000 | $860.00K | - | - |
FAQ
- What is Cytokinetics, Incorporated annual depreciation & amortization?
- What is the all time high annual D&A for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated annual D&A year-on-year change?
- What is Cytokinetics, Incorporated quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated quarterly D&A year-on-year change?
- What is Cytokinetics, Incorporated TTM depreciation & amortization?
- What is the all time high TTM D&A for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated TTM D&A year-on-year change?
What is Cytokinetics, Incorporated annual depreciation & amortization?
The current annual D&A of CYTK is $9.53M
What is the all time high annual D&A for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high annual depreciation & amortization is $11.89M
What is Cytokinetics, Incorporated annual D&A year-on-year change?
Over the past year, CYTK annual depreciation & amortization has changed by -$2.36M (-19.85%)
What is Cytokinetics, Incorporated quarterly depreciation & amortization?
The current quarterly D&A of CYTK is $2.29M
What is the all time high quarterly D&A for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high quarterly depreciation & amortization is $6.33M
What is Cytokinetics, Incorporated quarterly D&A year-on-year change?
Over the past year, CYTK quarterly depreciation & amortization has changed by -$121.00K (-5.03%)
What is Cytokinetics, Incorporated TTM depreciation & amortization?
The current TTM D&A of CYTK is $9.38M
What is the all time high TTM D&A for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high TTM depreciation & amortization is $13.48M
What is Cytokinetics, Incorporated TTM D&A year-on-year change?
Over the past year, CYTK TTM depreciation & amortization has changed by -$1.68M (-15.16%)